Literature DB >> 6722023

Erythromycin in the management of troublesome BCG lesions.

J T Power, I C Stewart, J D Ross.   

Abstract

We have recently seen six persons with troublesome post-BCG lesions. All lesions healed whilst on therapy with erythromycin for a period of 2-4 weeks. Erythromycin has some effect on the atypical mycobacteria ( Wolinsky et al. 1957) but its use has not previously been described for treatment of BCG lesions.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6722023

Source DB:  PubMed          Journal:  Br J Dis Chest        ISSN: 0007-0971


  4 in total

Review 1.  Bacille Calmette-Guérin lymphadenitis.

Authors:  Jafinder S Goraya; V S Virdi
Journal:  Postgrad Med J       Date:  2002-06       Impact factor: 2.401

2.  Pulmonary Mycobacterium kansasii infection successfully treated with a regimen containing erythromycin.

Authors:  P J Guest; M G Britton; H C Grundy; M D Yates
Journal:  Thorax       Date:  1988-06       Impact factor: 9.139

3.  Comparison of erythromycin and isoniazid in treatment of adverse reactions to BCG vaccination.

Authors:  S P Hanley; J Gumb; J T Macfarlane
Journal:  Br Med J (Clin Res Ed)       Date:  1985-03-30

4.  Isoniazid or rifampicin versus bacillus Calmette-Guérin (BCG).

Authors:  P A Camargos; J I Martins; M T Fonseca
Journal:  Indian J Pediatr       Date:  1991 Jan-Feb       Impact factor: 1.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.